Trials / Completed
CompletedNCT00346034
This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia
A 12 Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 357 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this protocol is to evaluate the long-term safety of pregabalin in patients who participated in the previous fibromyalgia Study A0081100 and who wish to receive open-label pregabalin therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | 150 to 600mg/day |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2006-06-29
- Last updated
- 2021-01-22
- Results posted
- 2009-03-13
Locations
51 sites across 12 countries: Canada, Denmark, France, Germany, India, Italy, Netherlands, Portugal, South Korea, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00346034. Inclusion in this directory is not an endorsement.